BRD4 Signaling Maintains the Differentiated State of β Cells

Area of Science:

• Endocrinology
• Molecular Biology
• Genetics

Background:

• Pancreatic beta cells dedifferentiate in diabetes, impacting insulin production.
• The role of Bromodomain-4 (BRD4) in beta cell differentiation is largely unknown.
• BRD4 is implicated in embryogenesis and cancer, suggesting potential regulatory functions.

Purpose of the Study:

• To investigate the function of BRD4 in pancreatic beta cell differentiation and its potential role in diabetes.
• To identify BRD4 mutations in diabetic patients and assess their impact on beta cell function.

Main Methods:

• Utilized calorie restriction models, conditional knockout mice (long-term and acute), and human islet organoids.
• Performed whole exome sequencing (WES) on 222 young diabetic patients to screen for BRD4 mutations.
• Assessed BRD4 expression, beta cell differentiation, and insulin synthesis under various experimental conditions.

Main Results:

• BRD4 expression was significantly reduced in human diabetic beta cells and increased with calorie restriction in diabetic mice.
• Impaired beta cell differentiation and reduced insulin synthesis were observed following BRD4 knockout or knockdown.
• A specific BRD4 mutation (p.R749C) was identified, potentially influencing diabetes development.
• ATF5 was confirmed as a direct target of the BRD4 pathway in beta cells.

Conclusions:

• BRD4 is essential for maintaining pancreatic beta cell differentiation and function.
• BRD4 signaling pathways, including its regulation of ATF5, are critical in beta cell homeostasis.
• Targeting BRD4-mediated networks presents a promising therapeutic avenue for diabetes treatment by preserving beta cell function.